Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1186/S12889-021-11451-Y | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
BackgroundAntimicrobial resistance is a global health emergency. Persons colonized with multidrug-resistant organisms (MDROs) are at risk for developing subsequent multidrug-resistant infections, as colonization represents an important precursor to invasive infection. Despite reports documenting the worldwide dissemination of MDROs, fundamental questions remain regarding the burden of resistance, metrics to measure prevalence, and determinants of spread. We describe a multi-site colonization survey protocol that aims to quantify the population-based prevalence and associated risk factors for colonization with high-threat MDROs among community dwelling participants and patients admitted to hospitals within a defined population-catchment area.MethodsResearchers in five countries (Bangladesh, Chile, Guatemala, Kenya, and India) will conduct a cross-sectional, population-based prevalence survey consisting of a risk factor questionnaire and collection of specimens to evaluate colonization with three high-threat MDROs: extended-spectrum cephalosporin-resistant Enterobacteriaceae (ESCrE), carbapenem-resistant Enterobacteriaceae (CRE), and methicillin-resistant Staphylococcus aureus (MRSA). Healthy adults residing in a household within the sampling area will be enrolled in addition to eligible hospitalized adults. Colonizing isolates of these MDROs will be compared by multilocus sequence typing (MLST) to routinely collected invasive clinical isolates, where available, to determine potential pathogenicity. A colonizing MDRO isolate will be categorized as potentially pathogenic if the MLST pattern of the colonizing isolate matches the MLST pattern of an invasive clinical isolate. The outcomes of this study will be estimates of the population-based prevalence of colonization with ESCrE, CRE, and MRSA; determination of the proportion of colonizing ESCrE, CRE, and MRSA with pathogenic characteristics based on MLST; identification of factors independently associated with ESCrE, CRE, and MRSA colonization; and creation an archive of ESCrE, CRE, and MRSA isolates for future study.DiscussionThis is the first study to use a common protocol to evaluate population-based prevalence and risk factors associated with MDRO colonization among community-dwelling and hospitalized adults in multiple countries with diverse epidemiological conditions, including low- and middle-income settings. The results will be used to better describe the global epidemiology of MDROs and guide the development of mitigation strategies in both community and healthcare settings. These standardized baseline surveys can also inform future studies seeking to further characterize MDRO epidemiology globally.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Sharma, Aditya | Hombre |
US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos |
| 2 | Luvsansharav, Ulzii-Orishikh | - |
US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos |
| 3 | Paul, Prabasaj | - |
US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos |
| 4 | Lutgring, Joseph D. | Hombre |
US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos |
| 5 | Call, Douglas R. | Hombre |
WASHINGTON STATE UNIV - Estados Unidos
Washington State University Pullman - Estados Unidos |
| 6 | Omulo, Sylvia | Mujer |
WASHINGTON STATE UNIV - Estados Unidos
Washington State University Pullman - Estados Unidos |
| 7 | Laserson, Kayla | Mujer |
US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos |
| 8 | ARAOS-BRALIC, RAFAEL IGNACIO | Hombre |
Universidad del Desarrollo - Chile
Millennium Initiat Collaborat Res Bacterial Resis - Chile Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile |
| 9 | MUNITA-SEPULVEDA, JOSE MANUEL | Hombre |
Universidad del Desarrollo - Chile
Millennium Initiat Collaborat Res Bacterial Resis - Chile Núcleo Milenio para la Investigación Colaborativa en Resistencia Antimicrobiana - Chile |
| 10 | Verani, Jennifer | Mujer |
KEMRI Complex - Kenia
Kenya Medical Research Institute - Kenia |
| 11 | Chowdhury, Fahmida | - |
Icddr B - Bangladesh
International Centre for Diarrhoeal Disease Research Bangladesh - Bangladesh |
| 12 | Muneer, Syeda Mah-E | Mujer |
Icddr B - Bangladesh
International Centre for Diarrhoeal Disease Research Bangladesh - Bangladesh |
| 13 | Espinosa-Bode, Andres | Hombre |
Interior Univ Valle - Guatemala
Universidad del Valle - Guatemala |
| 14 | Ramay, Brooke | Mujer |
WASHINGTON STATE UNIV - Estados Unidos
Univ Valle Guatemala - Guatemala Washington State University Pullman - Estados Unidos UNIVERSIDAD DEL VALLE DE GUATEMALA - Guatemala |
| 15 | Cordon-Rosales, Celia | Mujer |
Univ Valle Guatemala - Guatemala
UNIVERSIDAD DEL VALLE DE GUATEMALA - Guatemala |
| 16 | Kumar, C. P. Girish | - |
Natl Inst Epidemiol - India
National Institute of Epidemiology - India |
| 17 | Bhatnagar, Tarun | Hombre |
Natl Inst Epidemiol - India
National Institute of Epidemiology - India |
| 18 | Gupta, Neil | Hombre |
US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos |
| 19 | Park, Benjamin | Hombre |
US Ctr Dis Control & Prevent - Estados Unidos
National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos |
| 20 | Smith, Rachel M. | Mujer |
US Ctr Dis Control & Prevent - Estados Unidos
KEMRI Complex - Kenia Interior Univ Valle - Guatemala National Center for Emerging and Zoonotic Infectious Diseases - Estados Unidos Kenya Medical Research Institute - Kenia Universidad del Valle - Guatemala |
| Fuente |
|---|
| Centers for Disease Control and Prevention |
| U.S. Centers for Disease Control and Prevention (CDC) via Global Health Security Agenda |
| Broad Agency Announcement contract |
| Broad Agency |
| Agradecimiento |
|---|
| This work was supported by the U.S. Centers for Disease Control and Prevention (CDC) via Global Health Security Agenda cooperative agreements (GH001859, GH001207, GH002143, and GH002241) and a Broad Agency Announcement contract (#75D301-18C-02925). Authors with a CDC affiliation were employed by U.S. CDC at the time when this study was conceived, and the protocol was written. These CDC-employed authors contributed to the study as detailed below in Authors' contributions. Apart from these CDCemployed author contributions, the funder had no other role in the study. |
| This work was supported by the U.S. Centers for Disease Control and Prevention (CDC) via Global Health Security Agenda cooperative agreements (GH001859, GH001207, GH002143, and GH002241) and a Broad Agency Announcement contract (#75D301-18C-02925). Authors with a CDC affiliation were employed by U.S. CDC at the time when this study was conceived, and the protocol was written. These CDC-employed authors contributed to the study as detailed below in Authors’ contributions. Apart from these CDC-employed author contributions, the funder had no other role in the study. |